Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease

10.1038/s41380-022-01912-0

Saved in:

Bibliographic Details
Main Authors:	Varma, Vijay RR, Desai, Rishi JJ, Navakkode, Sheeja, Wong, Lik-Wei, Anerillas, Carlos, Loeffler, Tina, Schilcher, Irene, Mahesri, Mufaddal, Chin, Kristyn, Horton, Daniel BB, Kim, Seoyoung CC, Gerhard, Tobias, Segal, Jodi BB, Schneeweiss, Sebastian, Gorospe, Myriam, Sajikumar, Sreedharan, Thambisetty, Madhav
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Language:	English
Published:	SPRINGERNATURE 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Neurosciences Psychiatry Neurosciences & Neurology LONG-TERM POTENTIATION PROPENSITY-SCORE ANIMAL-MODEL MEMORY PERFORMANCE PLASTICITY COHORT CLAIMS MICE
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/239142
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Priorities for research consortia on Alzheimer's disease
by: Serge Gauthier, et al.
Published: (2018)

Agitation in alzheimer's disease is a manifestation of frontal lobe dysfunction
by: V. Senanarong, et al.
Published: (2018)

Synaptic Plasticity and the Mechanism of Alzheimer's Disease
Published: (2017)

Actions of the anti-angiogenic compound angiostatin in an animal model of Alzheimer's disease
by: Jae K. Ryu, et al.
Published: (2018)

A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress-mediated mitochondrial injury
by: P. Sompol, et al.
Published: (2018)

Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer's Disease in a Thai Population
by: Wanapaisan P.
Published: (2023)

Serum Glycoproteomics and Identification of Potential Mechanisms Underlying Alzheimer's Disease
by: Naphatthakarn Kerdsaeng, et al.
Published: (2022)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
by: S. Tangwongchai, et al.
Published: (2018)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
by: S. Tangwongchai, et al.
Published: (2018)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
by: S. Tangwongchai, et al.
Published: (2018)

α-secretase in Alzheimer's disease and beyond: Mechanistic, regulation and function in the shedding of membrane proteins
by: Bruno Vincent, et al.
Published: (2018)

The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients
by: Chatchawan Srisawat, et al.
Published: (2018)

Identification of a novel mutation in APP gene in a thai subject with early-onset Alzheimer’s disease
by: Vo Van Giau, et al.
Published: (2019)

Inhibition of lysine methyltransferase G9a/GLP reinstates long-term synaptic plasticity and synaptic tagging/capture by facilitating protein synthesis in the hippocampal CA1 area of APP/PS1 mouse model of Alzheimer's disease
by: Han, Javan Lee Tze, et al.
Published: (2022)

Erratum to: Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future (Alzheimer's & Dementia, (2020), 16, 11, (1571-1581), 10.1002/alz.12143)
by: Vincent C.T. Mok, et al.
Published: (2022)

Accuracy of Support-Vector Machines for Diagnosis of Alzheimer's Disease, Using Volume of Brain Obtained by Structural MRI at Siriraj Hospital
by: Yudthaphon Vichianin, et al.
Published: (2022)

The neuroprotective effect of ethanolic extract Ocimum sanctum Linn. in the regulation of neuronal density in hippocampus areas as a central autobiography memory on the rat model of Alzheimer's disease
by: Mataram, M.B.A., et al.
Published: (2021)

Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus
by: Pattama Panmak, et al.
Published: (2022)

M2 microglia activation and proNGF inhibition : Possible Mechanisms Behind Cognitive Improvements by Low-Dose Ionizing Radiation on Alzheimer's Disease; A Literature Review
by: Alifa, Hasna Noor
Published: (2022)

Age and gender differences for the behavioral phenotypes of 3xTg alzheimer's disease mice
by: Tanita Pairojana, et al.
Published: (2022)

Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats
by: Hiranya Pintana, et al.
Published: (2018)

The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use
by: Mayuri Shukla, et al.
Published: (2020)

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis
by: Mayuri Shukla, et al.
Published: (2022)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease
by: Lai, MKP, et al.
Published: (2021)

Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients
by: Tsang, SWY, et al.
Published: (2021)

The Amyloid-beta Pathway in Alzheimer's Disease
by: Hampel, Harald, et al.
Published: (2022)

Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
by: V. Senanarong, et al.
Published: (2018)

The 4-(Phenylsulfanyl) butan-2-one Improves Impaired Fear Memory Retrieval and Reduces Excessive Inflammatory Response in Triple Transgenic Alzheimer's Disease Mice
by: Peeraporn Varinthra, et al.
Published: (2022)

Neurochemical basis for symptomatic treatment of Alzheimer's disease
by: Francis, Paul T, et al.
Published: (2021)

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
by: Lee, Jasinda H, et al.
Published: (2021)

Melatonin attenuates streptozotocin-induced Alzheimer-like features in hyperglycemic rats
by: Utcharaporn Kamsrijai, et al.
Published: (2020)

Medicinal Plants - A Promising Breakthrough in the Management of Alzheimer's Disease Progression Compared to NSAID: A Systematic Review
by: Paulus Sugianto, -, et al.
Published: (2022)

THERAPEUTIC POTENTIAL OF CHIMERIC AMYLOID-BETA PRECURSOR PROTEIN INTRACELLULAR DOMAIN MUTANT IN ALZHEIMER'S DISEASE
by: PAWAN KUMAR
Published: (2020)

An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease
by: Lee, Chingli, et al.
Published: (2021)

Involvement of an altered 5-HT6 receptor function in behavioral symptoms of Alzheimer's disease
by: Marcos, Beatriz, et al.
Published: (2021)

Autoantibodies to GM1 and GQ1b alpha are not Biological Markers of Alzheimer's Disease
by: Miura, Yumako, et al.
Published: (2021)

Light-Induced Pupillary Responses in Alzheimer's Disease
by: Chougule, Pratik S, et al.
Published: (2021)

Genome Wide Profiling of Altered Gene Expression in the Neocortex of Alzheimer's Disease
by: Tan, Michelle G, et al.
Published: (2021)

Altered NCAM Expression Associated with the Cholinergic System in Alzheimer's Disease
by: Aisa, Barbara, et al.
Published: (2021)

A pilot study on salivary cortisol secretion and auditory P300 event-related potential in patients with physical disability-related stress
by: Vorasith Siripornpanich, et al.
Published: (2020)